Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1995 1
1998 1
1999 4
2000 4
2001 4
2002 7
2003 8
2004 6
2005 4
2006 5
2007 5
2008 2
2009 7
2010 4
2011 4
2012 3
2013 5
2014 3
2015 3
2016 2
2017 2
2019 2
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 16681826

74 results
Results by year
Filters applied: . Clear all
Page 1
LUD 00-009: phase 1 study of intensive course immunization with NY-ESO-1 peptides in HLA-A2 positive patients with NY-ESO-1-expressing cancer.
Bender A, Karbach J, Neumann A, Jäger D, Al-Batran SE, Atmaca A, Weidmann E, Biskamp M, Gnjatic S, Pan L, Hoffman E, Old LJ, Knuth A, Jäger E. Bender A, et al. Cancer Immun. 2007 Oct 19;7:16. Cancer Immun. 2007. PMID: 17944437 Free PMC article. Clinical Trial.
The ReNAissanCe of mRNA-based cancer therapy.
Van Lint S, Renmans D, Broos K, Dewitte H, Lentacker I, Heirman C, Breckpot K, Thielemans K. Van Lint S, et al. Expert Rev Vaccines. 2015 Feb;14(2):235-51. doi: 10.1586/14760584.2015.957685. Epub 2014 Sep 29. Expert Rev Vaccines. 2015. PMID: 25263094 Review.
Transient expansion of peptide-specific lymphocytes producing IFN-gamma after vaccination with dendritic cells pulsed with MAGE peptides in patients with mage-A1/A3-positive tumors.
Toungouz M, Libin M, Bulté F, Faid L, Lehmann F, Duriau D, Laporte M, Gangji D, Bruyns C, Lambermont M, Goldman M, Velu T. Toungouz M, et al. J Leukoc Biol. 2001 Jun;69(6):937-43. J Leukoc Biol. 2001. PMID: 11404379 Clinical Trial.
Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin.
Wobser M, Keikavoussi P, Kunzmann V, Weininger M, Andersen MH, Becker JC. Wobser M, et al. Cancer Immunol Immunother. 2006 Oct;55(10):1294-8. doi: 10.1007/s00262-005-0102-x. Epub 2005 Nov 29. Cancer Immunol Immunother. 2006. PMID: 16315030 Clinical Trial.
74 results
Jump to page
Feedback